3 Green Flags for Johnson & Johnson's Future

The healthcare giant is famous for its seminal consumer brands and diverse sources of revenue across virtually every sector of the healthcare industry. Positive data from a vaccine trial, a return to normal for the healthcare system, and the prospect of an exciting new surgical platform could move the conversation away from the company's history toward new sources of growth on the horizon. The U.S. Food and Drug Administration (FDA) recently posted data from a clinical trial saying Johnson & Johnson had met the requirements to obtain emergency use authorization for its COVID-19 vaccine.